Glenn Noronha
2017
In 2017, Glenn Noronha earned a total compensation of $871K as Chief Scientific Officer at Clearside Biomedical, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $93,308 |
|---|---|
| Option Awards | $459,671 |
| Salary | $313,639 |
| Other | $3,388 |
| Total | $870,956 |
Noronha received $459.7K in option awards, accounting for 53% of the total pay in 2017.
Noronha also received $93.3K in non-equity incentive plan, $313.6K in salary and $3.4K in other compensation.
Rankings
In 2017, Glenn Noronha's compensation ranked 9,639th out of 14,666 executives tracked by ExecPay. In other words, Noronha earned more than 34.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,639 out of 14,666 | 34th |
Division Manufacturing | 3,716 out of 5,772 | 36th |
Major group Chemicals And Allied Products | 1,287 out of 2,075 | 38th |
Industry group Drugs | 1,036 out of 1,731 | 40th |
Industry Pharmaceutical Preparations | 816 out of 1,333 | 39th |
Source: SEC filing on April 27, 2018.
Noronha's colleagues
We found two more compensation records of executives who worked with Glenn Noronha at Clearside Biomedical in 2017.